Soft contact lenses for controlled ocular delivery: 50 years in the making

Therapeutic Delivery

Volumn 4, Issue 9, 2013, Pages 1141-1161

  González Chomón, Clara ^a   Concheiro, Angel ^a   Alvarez Lorenzo, Carmen ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ACUVUE; AGENTS ACTING ON THE EYE; ALPHA TOCOPHEROL; AZULENE; CIPROFLOXACIN; CROMOGLYCATE DISODIUM; CYCLODEXTRIN; CYCLOSPORIN A; DEXAMETHASONE; DICLOFENAC; ETHOXZOLAMIDE; EYE DROPS; FUMARIC ACID; GENTAMICIN; KETOROLAC TROMETAMOL; KETOTIFEN; KETOTIFEN FUMARATE; LEVOFLOXACIN; LIDOCAINE; NANOCARRIER; NAPHAZOLINE; NATAMYCIN; NORFLOXACIN; OFLOXACIN; POLYMACON; PUERARIN; TIMOLOL; TIMOLOL MALEATE; UNCLASSIFIED DRUG; VANCOMYCIN;

BIOAVAILABILITY; CONTROLLED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; EYE INFECTION; HUMAN; HYDROGEL; INTRAOCULAR HYPERTENSION; MICROEMULSION; MOLECULAR IMPRINTING; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; REVIEW; SOFT CONTACT LENS;

EID: 84884163857     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.13.81     Document Type: Review

References (137)

1. Ciolino JB, Dohlman CH, Kohane DS. Contact lenses for drug delivery. Semin. Ophthalmol. 24, 156-160 (2009).
2. White CJ, Tieppo A, Byrne ME. Controlled drug release from contact lenses: a comprehensive review from 1965-present. J. Drug Deliv. Sci. Technol. 21, 369-384 (2011).
3. Wichterle O, Lim D. Cross-linked hydrophilic polymers and articles made therefrom. Patent US3220960 (1965).
4. Wichterle O. Method and apparatus for manufacturing hydrogel contact lenses. Patent UK GB1078715. Priority CS19630005041, 1963 (1965).
5. Sedlacek J. Possibilities of application of eye drugs with the aid of gel-contact lenses. Cs. Oftal. 21, 509-512 (1965).
6. Alvarez-Lorenzo C, Hiratani H, Concheiro A. Contact lenses for drug delivery: achieving sustained release with novel systems. Am. J. Drug Deliv. 4, 131-151 (2006).
7. Alvarez-Lorenzo C, Gonzalez-Chomon C, Concheiro A. Molecularly imprinted hydrogels for affinity-controlled and stimuli-responsive drug delivery. In : Smart Materials for Drug Delivery (Volume 2). Alvarez-Lorenzo C, Concheiro A (Eds). Royal Society of Chemistry, London, UK, 228-260 (2013).
8. Novack GD. Ophthalmic drug delivery: development and regulatory considerations. Clin. Pharmacol. Ther. 85, 539-543 (2009).
9. Kompella UB, Kadam RS, Lee VHL. Recent advances in ophthalmic drug delivery. Ther. Deliv. 1, 435-456 (2010).
10. Luk A, Junnarkar G. Critical challenges to the design of drug-eluting medical devices. Ther. Deliv. 4, 471-477 (2013).
11. Molokhia SA, Thomas SC, Garff KJ, Mandell KJ, Wirostko BM. Anterior eye segment drug delivery systems: current treatments and future challenges. J. Ocul. Pharm. Ther. 29, 92-105 (2013).
12. Gaudana T, Jwala J, Boddu SH, Mitra AS. Recent perspectives in ocular drug delivery. Pharm. Res. 26, 1197-1216 (2009).
13. Hughes PM, Olejnik O, Chang-Lin JE, Wilson CG. Topical and systemic drug delivery to the posterior segments. Adv. Drug Deliv. Rev. 57, 2010-2032 (2005).
14. Velpandian T. Intraocular penetration of antimicrobials agents in ophthalmic infections and drug delivery strategies. Expert Opin. Drug Deliv. 6, 255-270 (2009).
15. Wilson CG. Topical drug delivery in the eye. Exp. Eye Res. 78, 737-743 (2004).
16. Kearns VR, Williams RL. Drug delivery systems for the eye. Expert Rev. Med. Devices 6, 277-290 (2009).
17. Mainardes RM, Urban MCC, Cinto PO, Khalil NM, Chaud MV, Evangelista RC, Gremiao MP. Colloidal carriers for ophthalmic drug delivery. Curr. Drug Targets 6, 363-371 (2005).
18. Ludwig A. The use of mucoadhesive polymers in ocular drug delivery. Adv. Drug Deliv. Rev. 57, 1595-1639 (2005).
19. Mundada AS, Avari JG. In situ gelling polymers in ocular drug delivery systems: a review. Crit. Rev. Ther. Drug Carr. Syst. 26, 85-118 (2009).
20. Nagarwal RC, Kant S, Singh PN, Maiti P, Pandit JK. Polymeric nanoparticulate system: a potential approach for ocular drug delivery. J. Control. Release 136, 2-13 (2009).
21. Galezowski X. Sur la place cornéenne dans l'extraction de la cataracte et sur les moyens de prévenir la suppuration. Bull. Mem. Soc. Fr. Ophthalmol. 4, 217-226 (1886).
22. Gasset A, Kaufman HE. Therapeutic uses of hydrophilic contact lenses. Am. J. Ophtalmol. 69, 252-259 (1970).
23. Li CC, Chauhan A. Modeling ophthalmic drug delivery by soaked contact lenses. Ind. Eng. Chem. Res. 45, 3718-3734 (2006).
24. Matoba AY, McCulley JP. The effect of therapeutic soft contact lenses on antibiotic delivery to the cornea. Ophthalmology 92, 97-99 (1985).
25. Vandorselaer T, Youssfi H, Caspers-Valu LE, Dumont P, Vauthier L. Treatment of traumatic corneal abrasion with contact lens associated with topical nonsteroid anti-inflammatory drug (NSAID) and antibiotic: a safe, effective and comfortable solution. J. Fr. Ophtalmol. 24, 1025-1033 (2001).
26. Hiratani H, Fujiwara A, Tamiya Y, Mizutani Y, Alvarez-Lorenzo C. Ocular release of timolol from molecularly imprinted soft contact lenses. Biomaterials 26, 1293-1298 (2005).
27. Tieppo A, White CJ, Paine AC, Voyles ML, McBride MK, Byrne ME. Sustained in vivo release from imprinted therapeutic contact lenses. J. Control. Release 157, 391-397 (2012).
28. Jain MR. Drug delivery through soft contact lenses. Br. J. Ophthalmol. 72, 150-154 (1988).
29. Gumbel H. Curse and blessing of combat ophthalmology in the 20th and 21st Centuries. Klin. Monatsbl. Augenh. 226, 624-628 (2009).
30. Witcherle O, Lim D. Hydrophilic gels for biological use. Nature 185, 117-118 (1960).
31. McMahon TT, Zadnik K. Twenty-five years of contact lenses. Cornea 19, 730-740 (2000).
32. Nicolson PC, Vogt J. Soft contact lens polymers: an evolution. Biomaterials 22, 3273-3283 (2001).
33. Shah C, Raj S, Foulks GN. The evolution in therapeutic contact lenses. Ophthalmol. Clin. North Am. 16, 95-101 (2003).
34. Karlgard CCS, Wong NS, Jones LW, Moresoli C. In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materials. Int. J. Pharm. 257, 141-151 (2003).
35. Donshik PC. Extended wear contact lenses. Ophthalmol. Clin. North Am. 16, 79-83 (2003).
36. Lim L, Tan DTH, Chan WK. Therapeutic use of Bausch & Lomb Pure Vision contact lenses. CLAO J. 27, 179-185 (2001).
37. Kanpolat A, Ucakhan O. Therapeutic use of Focus Night & Day contact lenses. Cornea 22, 726-734 (2003).
38. Mely R. Therapeutic and cosmetic indications of Lotrafilcon. A silicone hydrogel extended-wear lenses. Ophthalmologica 218, 33-38 (2004).
39. Silbert JA. A review of therapeutic agents and contact lens wear. J. Am. Optom. Assoc. 67, 165-172 (1996).
40. Zegans ME, Becker HI, Budzik J, O'Toole G. The role of bacterial biofilms in ocular infections. DNA Cell Biol. 21, 415-420 (2002).
41. Gupta H, Aqil M. Contact lenses in ocular therapeutics. Drug Discov. Today 17, 522-527 (2012).
42. Waltman SR, Kaufman HE. Use of hydrophilic contact lenses to increase ocular penetration of topical drugs. Invest. Ophthalmol. Vis. Sci. 9, 250-255 (1970).
43. Ruben M, Watkins R. Pilocarpine dispensation for soft hydrophilic contact-lens. Br. J. Ophthalmol. 59, 455-458 (1975).
44. Hillman JS. Management of acute glaucoma with pilocarpine-soaked hydrophilic lens. Br. J. Ophthalmol. 58, 674-679 (1974).
45. Marmion VJ, Jain MR. Role of soft contact lenses and delivery of drugs. Trans. Ophthalmol. Soc. UK 96, 319-321 (1976).
46. Boone A, Hui A, Jones L. Uptake and release of dexamethasone phosphate from silicone hydrogel and group I, II, and IV hydrogel contact lenses. Eye Contact Lens 35, 260-267 (2009).
47. Rubinstein MP, Evans JE. Therapeutic contact lenses and eyedrops - is there a problem? Contact Lens Anterior Eye 20, 9-11 (1997).
48. Hull DS, Edelhauser HF, Hyndiuk RA. Ocular penetration of prednisolone and hydrophilic contact lens. Arch. Ophthalmol. 92, 413-416 (1974).
49. Matoba AY, McCulley JP. The effect of therapeutic soft contact-lenses on antibiotic delivery to the cornea. Ophthalmology 92, 97-99 (1985).
50. Jain MR. Drug delivery through soft contact lenses. Br. J. Ophthalmol. 72, 150-154 (1988).
51. Kaufman HE, Uotila MH, Gasset AR, Wood TO, Ellison ED. The medical uses of soft contact lenses. Trans. Am. Acad. Ophthalmol. Otolaryngol. 75, 361-373 (1971).
52. Salz JJ, Reader AL 3rd, Schwartz LJ, Van Le K. Treatment of corneal abrasions with soft contact lenses and topical diclofenac. J. Refract. Corneal Surg. 10, 640-646 (1994).
53. Refojo MF, Leong FL, Chan IM, Tolentino FI. Absorption and release of antibiotics by a hydrophilic implant for scleral buckling. Retina 3, 45-49 (1983).
54. Podos SM, Becker B, Asseff CF, Harstein J. Pilocarpine therapy with soft contact lenses. Am. J. Ophthalmol. 73, 336-341 (1972).
55. Lesher GA, Gunderson GG. Continuous drug-delivery through the use of disposable contact lenses. Optom. Vis. Sci. 70, 1012-1018 (1993).
56. Tian X, Iwatsu M, Kanai A. Disposable 1-Day Acuvue® contact lenses for the delivery of lomefloxacin to rabbits' eyes. CLAO J. 27, 209-215 (2001).
57. Tian X, Iwatsu M, Sado K, Kanai A. Studies on the uptake and release of fluoroquinolones by disposable contact lenses. CLAO J. 27, 216-220 (2001).
58. Hehl EM, Beck R, Luthard K, Guthoff R, Drewelow B. Improved penetration of aminoglycosides and fluoroquinolones into the aqueous humour of patients by means of Acuvue contact lenses. Eur. J. Clin. Pharmacol. 55, 317-323 (1999).
59. Heyrman TP, McDermott ML, Ubels JL, Edelhauser HF. Drug uptake and release by a hydrogel intraocular lens and the human crystalline lens. J. Cataract. Refract. Surg. 15, 169-175 (1989).
60. Chapman JM, Cheeks L, Green K. Drug-interaction with intraocular lenses of different materials. J. Cataract. Refract. Surg. 18, 456-459 (1992).
61. Weiner AL. Polymeric site-specific pharmacotherapy. In: Polymeric Drug Delivery Systems for the Eye. Domb AJ (Ed.). Wiley, Chichester, UK, 315-346 (1994).
62. Krejci L. Therapeutic use of scleral gel contact lenses. Cs. Oftal. 27, 104-109 (1971).
63. Krejci L, Brettschneider I, Praus R. Comparative study of fluorescein release from various types of therapeutic hydrophilic gel contact lenses. Cs. Oftal. 27, 285-291 (1971).
64. Praus R, Brettschneider I, Havranek M, Krejci L. Penetration of radioactive sulphate and glucose from hydrophilic gel contact lenses into the eye of rabbit. Ophthalmic Res. 6, 291-300 (1974).
65. Krejci L, Brettschneider I, Praus R. Hydrophilic gel contact lenses as a new drug delivery system in ophtalmology and as a therapeutic bandage lenses. Act. Univ. Carol. Med. 21, 387-396 (1975).
66. Nicolson PC, Vogt J. Soft contact lens polymers: an evolution. Biomaterials 22, 3273-3283 (2001).
67. Holden BA, Mertz GW. Critical oxygen level to avoid corneal edema for daily and extended wear contact lenses. Invest. Ophthalmol. Vis. Sci. 25, 1161-1167 (1984).
68. Wajs G, Meslard JC. Release of therapeutic agents from contact lenses. Crit. Rev. Ther. Drug Carr. Syst. 2, 275-289 (1986).
69. Kim SW, Bae YH, Okano T. Hydrogels: swelling, drug loading, and release. Pharm. Res. 9, 283-290 (1992).
70. Kunzler JF, McGee JA. Contact-lens materials. Chem. Ind. 16, 651-655 (1995).
71. Lloyd AW, Faragher RGA, Denyer SP. Ocular biomaterials and implants. Biomaterials 22, 769-785 (2001).
72. Phan CM, Subbaraman LN, Jones L. In vitro uptake and release of natamycin from conventional and silicone hydrogel contact lens materials. Eye Contact Lens 39, 162-168 (2013).
73. Soluri A, Hui A, Jones L. Delivery of ketotifen fumarate by commercial contact lens materials. Optom. Vis. Sci. 89, 1140-1149 (2012).
74. Pitt WG, Jack DR, Zhao Y, Nelson JL, Pruitt JD. Loading and release of a phospholipid from contact lenses. Optom. Vis. Sci. 88, 502-506 (2011).
75. Ciolino JB, Hoare TR, Iwata NG et al. A drug-eluting contact lens. Invest. Ophthalmol. Vis. Sci. 50, 3346-3352 (2009).
76. Ciolino JB, Hudson SP, Mobbs AN et al. A prototype antifungal contact lens. Invest. Ophthalmol. Vis. Sci. 52, 6286-6291 (2011).
77. Hyatt AJT, Rajan MS, Burling K, Ellington MJ, Tassoni A, Martin KR. Release of vancomycin and gentamicin from a contact lens versus a fibrin coating applied to a contact lens. Invest. Ophthalmol. Vis. Sci. 53, 1946-1952 (2012).
78. Bengani LC, Chauhan A. Extended delivery of an anionic drug by contact lens loaded with a cationic surfactant. Biomaterials 34, 2814-2821 (2013).
79. Ribeiro A, Sandez-Macho I, Casas M, Alvarez-Pérez S, Alvarez-Lorenzo C, Concheiro A. Poloxamine micellar solubilization of a-tocopherol for topical ocular treatment. Colloid Surface B 103, 550-557 (2013).
80. Peng CC, Kim J, Chauhan A. Extended delivery of hydrophilic drugs from silicone-hydrogel contact lenses containing vitamin E diffusion barriers. Biomaterials 31, 4032-4047 (2010).
81. Peng CC, Chauhan A. Extended cyclosporine delivery by silicone-hydrogel contact lenses. J. Control. Release 154, 267-274 (2011).
82. Peng CC, Burke MT, Chauhan A. Transport of topical anesthetics in vitamin E loaded silicone hydrogel contact lenses. Langmuir 28, 1478-1487 (2012).
83. Peng CC, Burke MT, Carbia BE, Plummer C, Chauhan A. Extended drug delivery by contact lenses for glaucoma therapy. J. Control. Release 162, 152-158 (2012).
84. Guzman-Aranguez A, Colligris B, Pintor J. Contact lenses: promising devices for ocular drug delivery. J. Ocul. Pharmacol. Th. 29, 189-199 (2013).
85. Gulsen D, Chauhan A. Ophthalmic drug delivery through contact lenses. Invest. Ophthalmol. Vis. Sci. 45, 2342-2347 (2004).
86. Gulsen D, Chauhan A. Dispersion of microemulsion drops in HEMA hydrogel: a potential ophthalmic drug delivery vehicle. Int. J. Pharm. 292, 95-117 (2005).
87. Danion A, Brochu H, Martin Y, Vermette P. Fabrication and characterization of contact lenses bearing surface-immobilized layers of intact liposomes. J. Biomed. Mater. Res. A 82, 41-51 (2007).
88. Danion A, Arsenault I, Vermette P. Antibacterial activity of contact lenses bearing surface-immobilized layers of intact liposomes loaded with levofloxacin. J. Pharm. Sci. 96, 2350-2363 (2007).
89. Kapoor Y, Chauhan A. Ophthalmic delivery of Cyclosporine A from Brij-97 microemulsion and surfactant-laden p-HEMA hydrogels. Int. J. Pharm. 361, 222-229 (2008).
90. Kapoor Y, Thomas JC, Tan G, John VT, Chauhan A. Surfactant-laden soft contact lenses for extended delivery of ophthalmic drugs. Biomaterials 30, 867-878 (2009).
91. Lu C, Yoganathan RB, Kociolek M, Allen C. Hydrogel containing silica shell cross-linked micelles for ocular drug delivery. J. Pharm. Sci. 102, 627-637 (2013).
92. Jung HJ, Abou-Jaoude M, Carbia BE, Plummer C, Chauhan A. Glaucoma therapy by extended release of timolol from nanoparticle loaded silicone-hydrogel contact lenses. J. Control. Release 165, 82-89 (2013).
93. Uchida R, Sato T, Tanigawa H, Uno K. Azulene incorporation and release by hydrogel containing methacrylamide propyltrimenthylammonium chloride, and its application to soft contact lens. J. Control. Release 92, 259-264 (2003).
94. Sato T, Uchida R, Tanigawa H, Uno K, Murakami A. Application of polymer gels containing side-chain phosphate groups to drug-delivery contact lenses. J. Appl. Polym. Sci. 98, 731-735 (2005).
95. Yamazaki Y, Matsunaga T, Syohji K, Arakawa T, Sato T. Effect of anionic/siloxy groups on the release of ofloxacin from soft contact lenses. J. Appl. Polym. Sci. 127, 5022-5027 (2013).
96. Kakisu K, Matsunga T, Kobayakawa S, Sato T, Tochikubo T. Development and efficacy of a drug-releasing soft contact lens. Invest. Ophthalmol. Vis. Sci. 54, 2551-2561 (2013).
97. Wang J, Liu F, Wei J. Hydrophilic silicone hydrogels with interpenetrating network structure for extended delivery of ophthalmic drugs. Polym. Adv. Technol. 23, 1258-1263 (2012).
98. Concheiro A, Alvarez-Lorenzo C. Chemically cross-linked and grafted cyclodextrin hydrogels: from nanostructures to drug-eluting medical devices. Adv. Drug Deliv. Rev. doi:10.1016/j.addr.04.015 (2013) (Epub ahead of print).
99. Xu J, Li X, Sun F. Cyclodextrin-containing hydrogels for contact lenses as a platform for drug incorporation and release. Acta Biomater. 6, 486-493 (2010).
100. Rosa dos Santos JF, Alvarez-Lorenzo C, Silva M et al. Soft contact lenses functionalized with pendant cyclodextrins for controlled drug delivery. Biomaterials 30, 1348-1355 (2009).
101. Rosa dos Santos JF, Couceiro R, Concheiro A, Torres-Labandeira JJ, Alvarez-Lorenzo C. Poly(hydroxyethyl methacrylate-co-methacrylated-b- cyclodextrin) hydrogels: synthesis, cytocompatibility, mechanical properties and drug loading/release properties. Acta Biomater. 4, 745-755 (2008).
102. Rosa dos Santos JF, Torres-Labandeira JJ, Matthijs N, Coenye T, Concheiro A, Alvarez-Lorenzo C. Functionalization of acrylic hydrogels with a-, b- or g-cyclodextrin modulates protein adsorption and antifungal delivery. Acta Biomater. 6, 3919-3926 (2010).
103. Cunliffe D, Kirby A, Alexander C. Molecularly imprinted drug delivery systems. Adv. Drug Deliv. Rev. 57, 1836-1853 (2005).
104. Whitcombe MJ, Chianella I, Larcombe L, Piletsky SA, Noble J, Porter R, Horgan A. The rational development of molecularly imprinted polymer-based sensors for protein detection. Chem. Soc. Rev. 40, 1547-1571 (2011).
105. Alvarez-Lorenzo C, Yañez F, Concheiro A. Ocular drug delivery from molecularly-imprinted contact lenses. J. Drug Deliv. Sci. Technol. 20, 237-248 (2010).
106. White CJ, Byrne ME. Molecularly imprinted therapeutic contact lenses. Expert Opin. Drug Deliv. 7, 765-780 (2010).
107. Andersson HS, Karlsson JG, Piletsky SA, Koch-Schmidt AC, Mosbach K, Nicholls IA. Study of the nature of recognition in molecularly imprinted polymers, II [1]: Influence of monomer-template ratio and sample load on retention and selectivity. J. Chromatogr. A Analyt. Technol. Biomed. Life Sci. 848, 39-49 (1999).
108. Ramström O, Ansell RJ. Molecular imprinting technology: challenges and prospects for the future. Chirality 10, 195-209 (1998)..
109. Alvarez-Lorenzo C, Concheiro A. Molecularly imprinted polymers for drug delivery. J. Chromatogr B Analyt. Technol. Biomed. Life Sci. 804, 231-245 (2004).
110. Alvarez-Lorenzo C, Hiratani H, Gómez-Amoza JL, Martinez-Pacheco R, Souto C, Concheiro A. Soft contact lenses capable of sustained delivery of timolol. J. Pharm. Sci. 91, 2182-2192 (2002).
111. Hiratani H, Alvarez-Lorenzo C. Timolol uptake and release by imprinted soft contact lenses made of N,N-diethylacrylamide and methacrylic acid. J. Control. Release 83, 223-230 (2002).
112. Hiratani H, Alvarez-Lorenzo C. The nature of backbone monomers determines the performance of imprinted soft contact lenses as timolol drug delivery systems. Biomaterials 25, 1105-1113 (2003).
113. Hiratani H, Mizutani H, Alvarez-Lorenzo C. Controlling drug release from imprinted hydrogels by modifying the characteristics of the imprinted cavities. Macromol. Biosci. 5, 728-733 (2005).
114. Yañez F, Chauhan A, Concheiro A, Alvarez-Lorenzo C. Timolol-imprinted soft contact lenses: influence of the template/functional monomer ratio and the hydrogel thickness. J. Appl. Polym. Sci. 122, 1333-1340 (2011).
115. Alvarez-Lorenzo C, Yañez F, Barreiro-Iglesias R, Concheiro A. Imprinted soft contact lenses as norfloxacin delivery systems. J. Control. Release 113, 236-244 (2006).
116. Tieppo A, Pate KM, Byrne ME. In vitro controlled release of an anti-inflammatory from daily disposable therapeutic contact lenses under physiological ocular tear flow. Eur. J. Pharm. Biopharm. 81, 170-177 (2012).
117. Malaekeh-Nikouei B, Ghaeni FA, Motamedshariaty VS, Mohajeri SA. Controlled release of prednisolone acetate from molecularly imprinted hydrogel contact lenses. J. Appl. Polym. Sci. 126, 387-394 (2012).
118. Hui A, Sheardown H, Jones L. Acetic and acrylic acid molecular imprinted model silicone hydrogel materials for ciprofloxacin-HCl delivery. Materials 5, 85-107 (2012).
119. Venkatesh S, Sizemore SP, Byrne ME. Biomimetic hydrogels for enhanced loading and extended release of ocular therapeutics. Biomaterials 28, 717-724 (2007).
120. Venkatesh S, Saha J, Pass S, Byrne M. Transport and structural analysis of molecular imprinted hydrogels for controlled drug delivery. Eur. J. Pharm. Biopharm. 69, 852-860 (2008).
121. Ali M, Horikawa S, Venkatesh S et al. Zero-order therapeutic release from imprinted hydrogel contact lenses within in vitro physiological ocular tear flow. J. Control. Release 124, 154-162 (2007).
122. Ribeiro A, Veiga F, Santos D, Torres-Labandeira JJ, Concheiro A, Alvarez-Lorenzo C. Bioinspired imprinted pHEMA-hydrogels for ocular delivery of carbonic anhydrase inhibitor drugs. Biomacromolecules 12, 701-709 (2011).
123. Abbate F, Casini A, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: x-ray crystallographic structure of the adduct of human isozyme II with a topically acting antiglaucoma sulfonamide. Bioorg. Med. Chem. Lett. 14, 2357-2361 (2004).
124. Ribeiro A, Veiga F, Santos D, Torres-Labandeira JJ, Concheiro A, Alvarez-Lorenzo C. Receptor-based biomimetic NVP/DMA contact lenses for loading/eluting carbonic anhydrase inhibitors. J. Membr. Sci. 383, 60-69 (2011).
125. Malaekeh-Nikouei B, Vahabzadeh SA, Mohajeri SA. Preparation of a molecularly imprinted soft contact lens as a new ocular drug delivery system for dorzolamide. Curr. Drug Deliv. 10, 279-285 (2013).
126. Yañez F, Concheiro A, Alvarez-Lorenzo C. Macromolecule release and smoothness of semi-interpenetrating PVP-pHEMA networks for comfortable soft contact lenses. Eur. J. Pharm. Biopharm. 69, 1094-1103 (2008).
127. Weeks A, Subbaraman LN, Jones L, Sheardown H. Physical entrapment of hyaluronic acid during synthesis results in extended release from model hydrogel and silicone hydrogel contact lens materials. Eye Contact Lens 39, 179-185 (2013).
128. Ali M, Byrne ME. Controlled release of high molecular weight hyaluronic acid from molecularly imprinted hydrogel contact lenses. Pharm. Res. 26, 714-726 (2009).
129. ClinicalTrials.gov.http://clinicaltrials.gov/ct2/results?term= contact+lens&pg=3(Accessed April 2013)
130. US FDA. Premarket notification (510(k)) guidance document for daily wear contact lenses. www.fda.gov/cdrh/ode/conta.html(Accessed April 2013)
131. ISO 18369-18361:2006/Amd 1:2009. www.iso.org/iso/home/store/catalogue-tc/ catalogue-detail.htm?csnumber=46070(Accessed June 2013)
132. Hutter JC. US FDA Group V: is a single grouping sufficient to describe SiH performance? November 2007. www.siliconehydrogels.org/editorials/nov-07. asp(Accessed April 2013)
133. Kiang T, Hutter J, Green JA, Phillips KS, Eydelman MB. Updating the contact lens classification system. www.fda.gov/downloads/AboutFDA/ CentersOffices/CDRH/CDRHFOIAElectronicReadingRoom/UCM279426.pdf(Accessed April 2013)
134. Silbert JA. Therapeutic uses of silicone hydrogels. www. siliconehydrogels.org/editorials/oct-05.asp(Accessed April 2013)
135. Pinilla-Lozano I, Polo-Llorens V, Larrosa-Poves JM, Pérez Oliván S, Izaquirre L, Gorricho J. Medium-water-content contact lenses ciprofloxacin saturation: differences between exposure times. Rev. Esp. Contact. (1998). www.oftalmo.com/sec/98-tomo-2/Ind-98-2.htm(Accessed April 2013)
136. Pinilla-Lozano I, Larrosa-Poves JM, Perez-Olivan S, Polo-Llorens V, Izaquirre L, Navascués J. Quinolones intraocular penetration depending on therapeutic contact lens wear. Rev. Esp. Contact. (1998). www.oftalmo.com/sec/ 98-tomo-2/Ind-98-2.htm(Accessed April 2013)
137. Corrective lens statistics. www.statisticbrain.com/corrective-lenses- statistics(Accessed April 2013)